Bank of New York Mellon’s Windtree Therapeutics Inc WINT Stock Holding History

Bank of New York Mellon’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,841	Closed	-$17K	–	4331
2015 Q4	$17K	Hold	5,841	–	–	﹤0.01%	4285
2015 Q3	$25K	Sell	5,841 -3	-0.1%	-$20	﹤0.01%	4304
2015 Q2	$56K	Buy	5,844 +1,146	+24%	+$16.1K	﹤0.01%	4154
2015 Q1	$78K	Hold	4,698	–	–	﹤0.01%	4096
2014 Q4	$76K	Hold	4,698	–	–	﹤0.01%	4104
2014 Q3	$121K	Hold	4,698	–	–	﹤0.01%	4004
2014 Q2	$117K	Buy	4,698 +20	+0.4%	+$511	﹤0.01%	3965
2014 Q1	$141K	Sell	4,678 -784	-14%	-$26.4K	﹤0.01%	3923
2013 Q4	$172K	Buy	5,462 +1,872	+52%	+$58.5K	﹤0.01%	3894
2013 Q3	$99K	Hold	3,590	–	–	﹤0.01%	3959
2013 Q2	$76K	Buy	+3,590	New	+$88.4K	﹤0.01%	3982

Other funds holding WINT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's WINT Position: Q1 2016 in Review

Bank of New York Mellon sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 5,841 shares — an estimated $17K sold.

Bank of New York Mellon first reported a position in WINT in Q2 2013 and held it in 11 quarters. The position peaked at $172K in Q4 2013. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

Bank of New York Mellon reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
Bank of New York Mellon sold 5,841 Windtree Therapeutics Inc shares in Q1 2016, an estimated $17K.
Bank of New York Mellon first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 11 quarters.
Bank of New York Mellon's Windtree Therapeutics Inc position peaked at $172K in Q4 2013.
34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Bank of New York Mellon's 13F filing for Q1 2016, filed 11 May 2016.